CINV Existing Pipeline Drugs Market Size, Share 2022

TABLE OF CONTENTS

1 Study Coverage
1.1 CINV Existing and Pipeline Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aloxi
1.2.3 Zofran Generic
1.2.4 Kytril Generic
1.2.5 Emend
1.2.6 Akynzeo
1.2.7 SUSTOL
1.2.8 Rolapitant
1.3 Market by Application
1.3.1 Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers Therapeutics
1.3.5 Hospital Pharmacies
1.3.6 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CINV Existing and Pipeline Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global CINV Existing and Pipeline Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global CINV Existing and Pipeline Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global CINV Existing and Pipeline Drugs Sales by Region
2.4.1 Global CINV Existing and Pipeline Drugs Sales by Region (2017-2022)
2.4.2 Global Sales CINV Existing and Pipeline Drugs by Region (2023-2028)
2.5 Global CINV Existing and Pipeline Drugs Revenue by Region
2.5.1 Global CINV Existing and Pipeline Drugs Revenue by Region (2017-2022)
2.5.2 Global CINV Existing and Pipeline Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global CINV Existing and Pipeline Drugs Sales by Manufacturers
3.1.1 Global Top CINV Existing and Pipeline Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global CINV Existing and Pipeline Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CINV Existing and Pipeline Drugs in 2021
3.2 Global CINV Existing and Pipeline Drugs Revenue by Manufacturers
3.2.1 Global CINV Existing and Pipeline Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by CINV Existing and Pipeline Drugs Revenue in 2021
3.3 Global CINV Existing and Pipeline Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global CINV Existing and Pipeline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global CINV Existing and Pipeline Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CINV Existing and Pipeline Drugs Sales by Type
4.1.1 Global CINV Existing and Pipeline Drugs Historical Sales by Type (2017-2022)
4.1.2 Global CINV Existing and Pipeline Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
4.2 Global CINV Existing and Pipeline Drugs Revenue by Type
4.2.1 Global CINV Existing and Pipeline Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global CINV Existing and Pipeline Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
4.3 Global CINV Existing and Pipeline Drugs Price by Type
4.3.1 Global CINV Existing and Pipeline Drugs Price by Type (2017-2022)
4.3.2 Global CINV Existing and Pipeline Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global CINV Existing and Pipeline Drugs Sales by Application
5.1.1 Global CINV Existing and Pipeline Drugs Historical Sales by Application (2017-2022)
5.1.2 Global CINV Existing and Pipeline Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
5.2 Global CINV Existing and Pipeline Drugs Revenue by Application
5.2.1 Global CINV Existing and Pipeline Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global CINV Existing and Pipeline Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
5.3 Global CINV Existing and Pipeline Drugs Price by Application
5.3.1 Global CINV Existing and Pipeline Drugs Price by Application (2017-2022)
5.3.2 Global CINV Existing and Pipeline Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America CINV Existing and Pipeline Drugs Market Size by Type
6.1.1 North America CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
6.1.2 North America CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
6.2 North America CINV Existing and Pipeline Drugs Market Size by Application
6.2.1 North America CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
6.2.2 North America CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
6.3 North America CINV Existing and Pipeline Drugs Market Size by Country
6.3.1 North America CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
6.3.2 North America CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe CINV Existing and Pipeline Drugs Market Size by Type
7.1.1 Europe CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
7.1.2 Europe CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
7.2 Europe CINV Existing and Pipeline Drugs Market Size by Application
7.2.1 Europe CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
7.2.2 Europe CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
7.3 Europe CINV Existing and Pipeline Drugs Market Size by Country
7.3.1 Europe CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
7.3.2 Europe CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Type
8.1.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Application
8.2.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Region
8.3.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America CINV Existing and Pipeline Drugs Market Size by Type
9.1.1 Latin America CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
9.1.2 Latin America CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
9.2 Latin America CINV Existing and Pipeline Drugs Market Size by Application
9.2.1 Latin America CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
9.2.2 Latin America CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
9.3 Latin America CINV Existing and Pipeline Drugs Market Size by Country
9.3.1 Latin America CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
9.3.2 Latin America CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Type
10.1.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Application
10.2.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Country
10.3.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Overview
11.2.3 Helsinn CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Helsinn CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Helsinn Recent Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Corporation Information
11.3.2 Heron Therapeutics Overview
11.3.3 Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Heron Therapeutics CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Heron Therapeutics Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Tesaro
11.5.1 Tesaro Corporation Information
11.5.2 Tesaro Overview
11.5.3 Tesaro CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tesaro CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tesaro Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CINV Existing and Pipeline Drugs Industry Chain Analysis
12.2 CINV Existing and Pipeline Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CINV Existing and Pipeline Drugs Production Mode & Process
12.4 CINV Existing and Pipeline Drugs Sales and Marketing
12.4.1 CINV Existing and Pipeline Drugs Sales Channels
12.4.2 CINV Existing and Pipeline Drugs Distributors
12.5 CINV Existing and Pipeline Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 CINV Existing and Pipeline Drugs Industry Trends
13.2 CINV Existing and Pipeline Drugs Market Drivers
13.3 CINV Existing and Pipeline Drugs Market Challenges
13.4 CINV Existing and Pipeline Drugs Market Restraints
14 Key Findings in The Global CINV Existing and Pipeline Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Aloxi
Table 3. Major Manufacturers of Zofran Generic
Table 4. Major Manufacturers of Kytril Generic
Table 5. Major Manufacturers of Emend
Table 6. Major Manufacturers of Akynzeo
Table 7. Major Manufacturers of SUSTOL
Table 8. Major Manufacturers of Rolapitant
Table 9. Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global CINV Existing and Pipeline Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global CINV Existing and Pipeline Drugs Sales by Region (2017-2022) & (Kg)
Table 12. Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2017-2022)
Table 13. Global CINV Existing and Pipeline Drugs Sales by Region (2023-2028) & (Kg)
Table 14. Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2023-2028)
Table 15. Global CINV Existing and Pipeline Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global CINV Existing and Pipeline Drugs Revenue Market Share by Region (2017-2022)
Table 17. Global CINV Existing and Pipeline Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global CINV Existing and Pipeline Drugs Revenue Market Share by Region (2023-2028)
Table 19. Global CINV Existing and Pipeline Drugs Sales by Manufacturers (2017-2022) & (Kg)
Table 20. Global CINV Existing and Pipeline Drugs Sales Share by Manufacturers (2017-2022)
Table 21. Global CINV Existing and Pipeline Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global CINV Existing and Pipeline Drugs Revenue Share by Manufacturers (2017-2022)
Table 23. CINV Existing and Pipeline Drugs Price by Manufacturers (2017-2022) &(USD/Kg)
Table 24. Global CINV Existing and Pipeline Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global CINV Existing and Pipeline Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CINV Existing and Pipeline Drugs as of 2021)
Table 26. CINV Existing and Pipeline Drugs Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers CINV Existing and Pipeline Drugs Product Offered
Table 28. Date of Manufacturers Enter into CINV Existing and Pipeline Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 31. Global CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 32. Global CINV Existing and Pipeline Drugs Sales Share by Type (2017-2022)
Table 33. Global CINV Existing and Pipeline Drugs Sales Share by Type (2023-2028)
Table 34. Global CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2017-2022)
Table 37. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2023-2028)
Table 38. CINV Existing and Pipeline Drugs Price by Type (2017-2022) & (USD/Kg)
Table 39. Global CINV Existing and Pipeline Drugs Price Forecast by Type (2023-2028) & (USD/Kg)
Table 40. Global CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 41. Global CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 42. Global CINV Existing and Pipeline Drugs Sales Share by Application (2017-2022)
Table 43. Global CINV Existing and Pipeline Drugs Sales Share by Application (2023-2028)
Table 44. Global CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global CINV Existing and Pipeline Drugs Revenue Share by Application (2017-2022)
Table 47. Global CINV Existing and Pipeline Drugs Revenue Share by Application (2023-2028)
Table 48. CINV Existing and Pipeline Drugs Price by Application (2017-2022) & (USD/Kg)
Table 49. Global CINV Existing and Pipeline Drugs Price Forecast by Application (2023-2028) & (USD/Kg)
Table 50. North America CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 51. North America CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 52. North America CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 55. North America CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 56. North America CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America CINV Existing and Pipeline Drugs Sales by Country (2017-2022) & (Kg)
Table 59. North America CINV Existing and Pipeline Drugs Sales by Country (2023-2028) & (Kg)
Table 60. North America CINV Existing and Pipeline Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America CINV Existing and Pipeline Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 63. Europe CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 64. Europe CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 67. Europe CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 68. Europe CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe CINV Existing and Pipeline Drugs Sales by Country (2017-2022) & (Kg)
Table 71. Europe CINV Existing and Pipeline Drugs Sales by Country (2023-2028) & (Kg)
Table 72. Europe CINV Existing and Pipeline Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe CINV Existing and Pipeline Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 75. Asia Pacific CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 76. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 79. Asia Pacific CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 80. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific CINV Existing and Pipeline Drugs Sales by Region (2017-2022) & (Kg)
Table 83. Asia Pacific CINV Existing and Pipeline Drugs Sales by Region (2023-2028) & (Kg)
Table 84. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific CINV Existing and Pipeline Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 87. Latin America CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 88. Latin America CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 91. Latin America CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 92. Latin America CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America CINV Existing and Pipeline Drugs Sales by Country (2017-2022) & (Kg)
Table 95. Latin America CINV Existing and Pipeline Drugs Sales by Country (2023-2028) & (Kg)
Table 96. Latin America CINV Existing and Pipeline Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America CINV Existing and Pipeline Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Type (2017-2022) & (Kg)
Table 99. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Type (2023-2028) & (Kg)
Table 100. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Application (2017-2022) & (Kg)
Table 103. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Application (2023-2028) & (Kg)
Table 104. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Country (2017-2022) & (Kg)
Table 107. Middle East and Africa CINV Existing and Pipeline Drugs Sales by Country (2023-2028) & (Kg)
Table 108. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Major Businesses
Table 112. GlaxoSmithKline CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 113. GlaxoSmithKline CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GlaxoSmithKline Recent Developments
Table 115. Helsinn Corporation Information
Table 116. Helsinn Description and Major Businesses
Table 117. Helsinn CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 118. Helsinn CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Helsinn Recent Developments
Table 120. Heron Therapeutics Corporation Information
Table 121. Heron Therapeutics Description and Major Businesses
Table 122. Heron Therapeutics CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 123. Heron Therapeutics CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Heron Therapeutics Recent Developments
Table 125. Merck Corporation Information
Table 126. Merck Description and Major Businesses
Table 127. Merck CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 128. Merck CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Merck Recent Developments
Table 130. Tesaro Corporation Information
Table 131. Tesaro Description and Major Businesses
Table 132. Tesaro CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 133. Tesaro CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tesaro Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. CINV Existing and Pipeline Drugs Distributors List
Table 138. CINV Existing and Pipeline Drugs Customers List
Table 139. CINV Existing and Pipeline Drugs Market Trends
Table 140. CINV Existing and Pipeline Drugs Market Drivers
Table 141. CINV Existing and Pipeline Drugs Market Challenges
Table 142. CINV Existing and Pipeline Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. CINV Existing and Pipeline Drugs Product Picture
Figure 3. Global CINV Existing and Pipeline Drugs Market Share by Type in 2021 & 2028
Figure 3. Aloxi Product Picture
Figure 4. Zofran Generic Product Picture
Figure 5. Kytril Generic Product Picture
Figure 6. Emend Product Picture
Figure 7. Akynzeo Product Picture
Figure 8. SUSTOL Product Picture
Figure 9. Rolapitant Product Picture
Figure 10. Global CINV Existing and Pipeline Drugs Market Share by Application in 2021 & 2028
Figure 11. Hospitals
Figure 12. Specialty Clinics
Figure 13. Diagnostic Centers Therapeutics
Figure 14. Hospital Pharmacies
Figure 15. Drugstores
Figure 16. CINV Existing and Pipeline Drugs Report Years Considered
Figure 17. Global CINV Existing and Pipeline Drugs Sales 2017-2028 (Kg)
Figure 18. Global CINV Existing and Pipeline Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global CINV Existing and Pipeline Drugs Revenue 2017-2028 (US$ Million)
Figure 20. Global CINV Existing and Pipeline Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2017-2022)
Figure 22. Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2023-2028)
Figure 23. North America CINV Existing and Pipeline Drugs Sales YoY (2017-2028) & (Kg)
Figure 24. North America CINV Existing and Pipeline Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe CINV Existing and Pipeline Drugs Sales YoY (2017-2028) & (Kg)
Figure 26. Europe CINV Existing and Pipeline Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific CINV Existing and Pipeline Drugs Sales YoY (2017-2028) & (Kg)
Figure 28. Asia-Pacific CINV Existing and Pipeline Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America CINV Existing and Pipeline Drugs Sales YoY (2017-2028) & (Kg)
Figure 30. Latin America CINV Existing and Pipeline Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa CINV Existing and Pipeline Drugs Sales YoY (2017-2028) & (Kg)
Figure 32. Middle East & Africa CINV Existing and Pipeline Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The CINV Existing and Pipeline Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of CINV Existing and Pipeline Drugs in the World: Market Share by CINV Existing and Pipeline Drugs Revenue in 2021
Figure 35. Global CINV Existing and Pipeline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 39. Global CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 40. North America CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 42. North America CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 43. North America CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 44. North America CINV Existing and Pipeline Drugs Sales Share by Country (2017-2028)
Figure 45. North America CINV Existing and Pipeline Drugs Revenue Share by Country (2017-2028)
Figure 46. U.S. CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Canada CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Europe CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 49. Europe CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 50. Europe CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 52. Europe CINV Existing and Pipeline Drugs Sales Share by Country (2017-2028)
Figure 53. Europe CINV Existing and Pipeline Drugs Revenue Share by Country (2017-2028)
Figure 54. Germany CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. France CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Italy CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Russia CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific CINV Existing and Pipeline Drugs Sales Share by Region (2017-2028)
Figure 64. Asia Pacific CINV Existing and Pipeline Drugs Revenue Share by Region (2017-2028)
Figure 65. China CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Japan CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. India CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Australia CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Taiwan CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Philippines CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 76. Latin America CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 77. Latin America CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 78. Latin America CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 79. Latin America CINV Existing and Pipeline Drugs Sales Share by Country (2017-2028)
Figure 80. Latin America CINV Existing and Pipeline Drugs Revenue Share by Country (2017-2028)
Figure 81. Mexico CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa CINV Existing and Pipeline Drugs Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa CINV Existing and Pipeline Drugs Revenue Share by Country (2017-2028)
Figure 90. Turkey CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. U.A.E CINV Existing and Pipeline Drugs Revenue (2017-2028) & (US$ Million)
Figure 93. CINV Existing and Pipeline Drugs Value Chain
Figure 94. CINV Existing and Pipeline Drugs Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

DOWNLOAD SAMPLE